Press release
One "Target" for a Month: Creative Biolabs Features TNFRSF9
Creative Biolabs introduces its range of TNFRSF9-related antibody reagents.New York, USA - July 10, 2024 - The growing interest in TNFRSF9 (also known as CD137, 4-1BB) stems from its role as a co-stimulatory receptor on T cells, which can enhance immune responses against tumors. Research has shown that activating TNFRSF9 can significantly boost the efficacy of cancer immunotherapies. To synchronize with recent industry news highlighting the potential of TNFRSF9-targeted therapies to overcome the limitations of existing treatments and deliver durable anti-tumor responses, Creative Biolabs specifies their anti-TNFRSF9 engineered antibodies [https://www.creativebiolabs.net/symbolsearch_TNFRSF9_2.htm] in the monthly briefing.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
I: Leading in with the Omnipresent Hi-Affi Trademark
"First of all, a short overview of our Hi-Affi Trademark platform to get you a clearer picture of our antibody performance," according to the scientist delivering the presentation, "which is a concert of advanced DNA technologies and powerful cell-free expression systems."
Almost all production work of recombinant antibodies [https://www.creativebiolabs.net/hi-affi-tm-recombinant-antibodies.htm] is run by the Hi-Affi Trademark platform, covering antibodies of different working modalities (blocking, neutralizing, etc.), antibodies against divergent targets (epitope-specific, mRNA encoded, etc.), and antibodies originated from different species (chicken, rabbit, etc.), with which the yielding reagents will be validated to have over 98% purity, high affinity, and reproducibility.
II: Catalog presentation
The scientist revealed a list of their research-use-only antibodies that are readily available for global delivery, and announced that the list is growing to cover more isotypes and more validated applications.
* Rat Anti-TNFRSF9 Recombinant Antibody
* Recombinant Mouse Anti-Human TNFRSF9 Antibody
* Hamster Anti-TNFRSF9 Recombinant Antibody
* Rat Anti-TNFRSF9 Recombinant Antibody
* Rat Anti-TNFRSF9 Recombinant Antibody
* Human Anti-TNFRSF9 Recombinant Antibody
* Human Anti-TNFRSF9 Recombinant Antibody
III: Case study: urelumab-a therapeutic breakthrough
Furthermore, a candidate that had received its final clinical results not a while ago was discussed-urelumab, an agonistic antibody targeting 4-1BB, making it a valuable tool in the fight against cancer. Two studies that evaluated urelumab in combination with cetuximab or nivolumab in patients with select, advanced solid tumors were reported in the paper.
"For relevant studies, we have anti-human 4-1BB recombinant antibodies [https://www.creativebiolabs.net/Anti-Human-4-1BB-Therapeutic-Antibody-Urelumab-13548.htm]," the scientist added, "which have been validated to be positive against native human antigen. Tested data are provided on the product page to help researchers know more about how they work in specific assays, like WB and ELISA."
IV: Outlook
Creative Biolabs prides itself on its commitment to innovation and collaboration and is poised to play a pivotal role in advancing TNFRSF9-targeted therapies.
"As the research community continues to explore the full potential of such critical factors in immunotherapy, we remain dedicated to driving scientific progress." The scientist summarized.
For more information about Creative Biolabs' TNFRSF9 antibodies and to explore their comprehensive product offerings, visit https://www.creativebiolabs.net or contact their expert team.
Company Overview
Creative Biolabs is a biotechnology company specializing in antibody development, engineering, and production. With a strong focus on innovation and customer service, Creative Biolabs provides a wide range of high-quality antibody products to support biomedical research and drug development worldwide.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=one-target-for-a-month-creative-biolabs-features-tnfrsf9]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creativebiolabs.net
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release One "Target" for a Month: Creative Biolabs Features TNFRSF9 here
News-ID: 3575212 • Views: …
More Releases from Getnews
 
                                            
                                                    Essex Property Care Ensures Safer and More Efficient Drainage Maintenance                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761840505.jpg
A close-up of a house gutter filled with autumn leaves under warm sunlight, representing seasonal maintenance and professional gutter cleaning services in Chelmsford, Essex.
Essex Property Care (EPC Drainage & Pest Control) in Chelmsford enhances property protection with modern, ladder-free gutter cleaning using a ground-based vacuum system. The fully insured family-run company ensures safer, disruption-free maintenance for homes and businesses across Essex, focusing on preventive care, transparency, and long-term property…  
                                        
                                     
                                            
                                                    Elder Care Homecare Reaffirms Commitment, Continues Offering Premier Home Care S …                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761935588.jpg
Elder Care Homecare reaffirms its commitment to providing premier home care services in Manhattan, ensuring seniors receive the compassionate, personalized care they deserve. With a dedicated team of professionals, the agency continues to enhance the quality of life for families, offering essential support in the comfort of their loved one's home.
Elder Care Homecare reaffirms its commitment to Manhattan families by continuing to provide trusted, compassionate senior home care services.…  
                                        
                                     
                                            
                                                    Cooperative Home Care Continues to Prioritize Compassionate Companion Home Care  …                                                
                                            
                                        
                                            Image: https://www.globalnewslines.com/uploads/2025/10/1761935235.jpg
Cooperative Home Care in St. Louis, MO, continues to prioritize compassionate companion home care. This heartwarming image captures the essence of their services, as caregivers offer companionship, emotional support, and personalized care to seniors, ensuring they live comfortably and safely at home. With a focus on building meaningful connections, Cooperative Home Care enhances the lives of seniors and provides peace of mind to their families.
Cooperative Home Care in St.…  
                                        
                                     
                                            
                                                    Leonard Cagno Urges Professionals to Redefine Success Through Balance, Adaptabil …                                                
                                            
                                        
                                            Entrepreneur and Partner Leonard Cagno shares lessons from aviation to business leadership, calling for a renewed focus on personal growth and wellness in the modern workplace
Entrepreneur and business leader Leonard Cagno is using his recent feature spotlight to call attention to a growing challenge in today's workforce: the lack of balance and adaptability in the pursuit of success. Drawing on lessons from his career as a flight instructor, financial advisor,…  
                                        
                                    More Releases for TNFRSF9
                                                    Tumor Necrosis Factor Receptor Superfamily Member 9: North America to Retain its …                                                
                                            
                                        
                                            Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) pipeline Target constitutes close to 35 molecules. Out of which approximately 31 molecules are developed by companies and remaining by the universities/institutes.
To evaluate factors influencing Tumor Necrosis Factor Receptor Superfamily Member 9, Market Research Hub (MRH) has included a report titled “Tumor Necrosis Factor Receptor…  
                                        
                                    